Login
Subscribe
Take a FREE Trial
About Us
Contact us
RSS
24 May 2013
Search
The Pharma Letter
Home
7 Day Premium Trial
Pharmaceuticals
Biotechnology
Generics
Events
Companies
Drugs
Subscribe
Anchen Pharmaceuticals Articles
Shire's Dermagraft cleared in Canada; settles Intuniv litigation
6 September 2012
US Court upholds AstraZeneca Seroquel XR patent
30 March 2012
Par Pharma to acquire niche generics producer Anchen for $410 million
25 August 2011
Showing 1-3 of 3 articles
1
Hot Topics
Most Read
Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
Boehringer Ingelheim gets FDA warning letter on cGMP failures
Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
Boehringer Ingelheim gets FDA warning letter on cGMP failures
Positive new data on Novartis' Galvus in elderly type 2 diabetes patients